See also this year's filing and all EDGAR filings for this company.
PDF Report 0001579428_2018_Axsome_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001579428')"} |
Graph
Absolute values for 0001579428, Axsome Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 35,299,541 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 68,071 |
| 3 | remainder_Assets | 187,952 |
| 4 | LiabilitiesCurrent | 12,175,336 |
| 5 | LiabilitiesNoncurrent | 6,663,005 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,206,691 |
| 9 | ResearchAndDevelopmentExpense | 19,957,616 |
| 10 | remainder_Expenses | 646,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -1,133,085 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 35,555,564 |
| 1 | Liabilities | 18,838,341 |
| 2 | Expenses | 27,810,307 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 16,717,223 |
| 5 | NetIncome | -28,943,392 |
| 6 | ComprehensiveNetIncome | -28,943,392 |
| 7 | BaseVar | 41,668,648 |
| 8 | EconomicCapitalRatio | -0.00698 |